Larvol Delta - aTyr-pharma-announces-dosing-of-first-patient-in-phase-2-trial-of-ATYR1923-in-Covid19-patients-with-severe-respiratory-complications

Stalaris (ATYR1923) - aTyr Pharma, Kyorin

https://www.globenewswire.com/news-release/2020/06/15/2047937/0/en/aTyr-Pharma-Announces-Dosing-of-First-Patient-in-Phase-2-Trial-of-ATYR1923-in-COVID-19-Patients-with-Severe-Respiratory-Complications.html

Jun 15, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next